PROLYMPHOCYTIC LEUKEMIA
Clinical trials for PROLYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PROLYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for PROLYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail tested for Tough-to-Treat blood cancers
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of combining the drug acalabrutinib with other cancer medications for patients with chronic lymphocytic leukemia (CLL) and related blood cancers. It involved 69 patients, some who had been treated before and some …
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New combo therapy targets tough blood cancers
Disease control CompletedThis study tested whether combining two drugs could help control chronic lymphocytic leukemia and related blood cancers. It included 41 adults whose cancer had returned after previous treatment or who hadn't yet received treatment. Researchers gave patients an antibody drug that …
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for blood cancer patients: gentler transplants from family donors
Disease control CompletedThis study tested a less intense bone marrow transplant procedure for adults with various blood cancers who needed a transplant but did not have a fully matched donor. It used stem cells from a half-matched family member (like a parent, child, or sibling) after a milder pre-trans…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC